C-Reactive Protein Is Not the Driver Factor in Ulcerative Colitis

Area of Science:

• Immunology
• Gastroenterology
• Biochemistry

Background:

• C-reactive protein (CRP) is a nonspecific marker for inflammation.
• Its role in ulcerative colitis (UC) progression and treatment efficacy is under investigation.
• Current evidence lacks strong support for CRP directly influencing UC advancement.

Purpose of the Study:

• To investigate the direct role of C-reactive protein (CRP) in the pathogenesis of ulcerative colitis (UC).
• To evaluate if CRP deficiency impacts the severity and progression of DSS-induced colitis in a mouse model.

Main Methods:

• Established a dextran sulfate sodium (DSS)-induced ulcerative colitis mouse model using CRP-deficient and wild-type mice.
• Assessed phenotypic parameters: body weight, colon length, spleen weight.
• Evaluated colon histopathology, inflammatory factor expression, and intestinal mucus layer integrity.

Main Results:

• CRP deficiency did not significantly alter the phenotype, physiological, or biochemical indices of DSS-induced colitis.
• Antibiotic treatment to control gut microbiota did not reveal significant variations in CRP-deficient mice.
• Survival rates were comparable between CRP-deficient and wild-type mice.

Conclusions:

• C-reactive protein (CRP) may not directly mediate ulcerative colitis.
• CRP is likely a marker of inflammation rather than a causative factor in this model.
• Further research is needed to clarify CRP's role in human UC due to mouse model limitations.